319 related articles for article (PubMed ID: 34335480)
21. High-risk factors for lymph node metastasis in contralateral central compartment in unilateral papillary thyroid carcinoma（cT1N0）.
Zhou B; Qin J
Eur J Surg Oncol; 2021 Apr; 47(4):882-887. PubMed ID: 33092967
[TBL] [Abstract][Full Text] [Related]
22. PTC located in the upper pole is more prone to lateral lymph node metastasis and skip metastasis.
Dou Y; Hu D; Chen Y; Xiong W; Xiao Q; Su X
World J Surg Oncol; 2020 Jul; 18(1):188. PubMed ID: 32723382
[TBL] [Abstract][Full Text] [Related]
23. Predictive Value of Jugulo-omohyoid Lymph Nodes in Lateral Lymph Node Metastasis of Papillary Thyroid Cancer.
Cai H; Zhuge L; Huang Z; Wang S; Shi P; Yan D; Wei M; Niu L; Li Z
BMC Endocr Disord; 2024 May; 24(1):74. PubMed ID: 38773428
[TBL] [Abstract][Full Text] [Related]
24. Skip metastasis in papillary thyroid carcinoma is difficult to predict in clinical practice.
Nie X; Tan Z; Ge M
BMC Cancer; 2017 Oct; 17(1):702. PubMed ID: 29070029
[TBL] [Abstract][Full Text] [Related]
25. Predicting skip metastasis in lateral lymph nodes of papillary thyroid carcinoma based on clinical and ultrasound features.
Zhao M; Shi X; Zou Z; Wen R; Lu Y; Li J; Cao J; Zhang B
Front Endocrinol (Lausanne); 2023; 14():1151505. PubMed ID: 37229457
[TBL] [Abstract][Full Text] [Related]
26. Cervical Lymph Node Metastases of Papillary Thyroid Carcinoma, in the Central and Lateral Compartments, in Children and Adolescents: Predictive Factors.
Spinelli C; Tognetti F; Strambi S; Morganti R; Massimino M; Collini P
World J Surg; 2018 Aug; 42(8):2444-2453. PubMed ID: 29383423
[TBL] [Abstract][Full Text] [Related]
27. Nomogram for predicting skip metastasis in cN0 papillary thyroid cancer patients at increased risk of lymph node metastasis.
Li F; Zhou FJ; Zhu TW; Qiu HL; Zhang XT; Ruan BW; Huang DY
Adv Clin Exp Med; 2023 Jul; 32(7):753-761. PubMed ID: 36603142
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic value of contrast-enhanced ultrasonography in the preoperative evaluation of lymph node metastasis in papillary thyroid carcinoma: a single-center retrospective study.
Yang Z; Wang X; Tao T; Zou J; Qiu Z; Wang L; Du H; Chen N; Yin X
BMC Surg; 2023 Oct; 23(1):325. PubMed ID: 37875825
[TBL] [Abstract][Full Text] [Related]
29. [Risk factors of skip lateral cervical lymph node metastasis in papillary thyroid carcinoma].
Gao J; Xin Y; Yang L; Liu Y; Tian Z; Shang X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Jul; 36(7):528-532;539. PubMed ID: 35822381
[No Abstract] [Full Text] [Related]
30. Risk factors for level V lymph node metastases in solitary papillary thyroid carcinoma with clinically lateral lymph node metastases.
Yang J; Gong Y; Yan S; Zhu J; Li Z; Gong R
Cancer Med; 2016 Aug; 5(8):2161-8. PubMed ID: 27368106
[TBL] [Abstract][Full Text] [Related]
31. Risk factors of skip lateral lymph node metastasis in papillary thyroid carcinoma.
Hou J; Zhang Y; Fan Y; Wu B
Eur Arch Otorhinolaryngol; 2021 Feb; 278(2):493-498. PubMed ID: 32607832
[TBL] [Abstract][Full Text] [Related]
32. Experience and analysis of Delphian lymph node metastasis in patients with papillary thyroid carcinoma.
Kim WW; Yang SI; Kim JH; Choi YS; Park YH; Kwon SK
World J Surg Oncol; 2012 Oct; 10():226. PubMed ID: 23110552
[TBL] [Abstract][Full Text] [Related]
33. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
34. [Related factors analysis for lymph node metastasis in papillary thyroid carcinoma: a series of 2 073 patients].
Sun QH; Zhang L; Yang JB; Liu YW; Liang F; Shi H; Liu ZW; Chen G; Chen SG; Shang ZH; Hu SB; Dong YW; Li YL; Li XY
Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):592-598. PubMed ID: 28789509
[No Abstract] [Full Text] [Related]
35. Thyroid Lobectomy for T1 Papillary Thyroid Carcinoma in Pediatric Patients.
Sudoko CK; Jenks CM; Bauer AJ; Isaza A; Mostoufi-Moab S; Surrey LF; Bhatti TR; Franco A; Adzick NS; Kazahaya K
JAMA Otolaryngol Head Neck Surg; 2021 Nov; 147(11):943-950. PubMed ID: 34554217
[TBL] [Abstract][Full Text] [Related]
36. Lymph node management in clinically node-negative patients with papillary thyroid carcinoma.
Vergez S; Sarini J; Percodani J; Serrano E; Caron P
Eur J Surg Oncol; 2010 Aug; 36(8):777-82. PubMed ID: 20584589
[TBL] [Abstract][Full Text] [Related]
37. Nomograms to predict ipsilateral and contralateral central lymph node metastasis in clinically lymph node-negative patients with solitary isthmic classic papillary thyroid carcinoma.
Feng JW; Qu Z; Ye J; Hong LZ; Liu SY; Wang F; Jiang Y; Hu J
Surgery; 2021 Dec; 170(6):1670-1679. PubMed ID: 34275617
[TBL] [Abstract][Full Text] [Related]
38. Papillary thyroid carcinoma located in the isthmus or upper third is associated with Delphian lymph node metastasis.
Chai YJ; Kim SJ; Choi JY; Koo do H; Lee KE; Youn YK
World J Surg; 2014 Jun; 38(6):1306-11. PubMed ID: 24366273
[TBL] [Abstract][Full Text] [Related]
39. Features of Lymph Node Metastasis and Structural Recurrence in Papillary Thyroid Carcinoma Located in the Upper Portion of the Thyroid: A Retrospective Cohort Study.
Heng Y; Feng S; Yang Z; Cai W; Qiu W; Tao L
Front Endocrinol (Lausanne); 2021; 12():793997. PubMed ID: 35145480
[TBL] [Abstract][Full Text] [Related]
40. Prospective outcomes of selective lymph node dissection for papillary thyroid carcinoma based on preoperative ultrasonography.
Sugitani I; Fujimoto Y; Yamada K; Yamamoto N
World J Surg; 2008 Nov; 32(11):2494-502. PubMed ID: 18784956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
